Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Cowen Health Care Conference Transcript

Mar 08, 2023 / 03:30PM GMT
Release Date Price: €270.15 (+0.17%)
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst

Again, my name is Josh Jennings. I'm leading the medical devices team here at TD Cowen. And we're excited to continue down the medical devices track at the 43rd Annual TD Cowen Health Care Conference. We're thrilled to have the Insulet team here today to join us for a fireside chat. Let me make a quick introduction. We have President and CEO, Jim Hollingshead; and Executive Vice President and Chief Financial Officer, Wayde McMillan.

Gentlemen, thanks so much for coming over at -- I guess, south from your headquarters, is that right, and coming down to Boston and having this discussion. We're going to let you kick off with some introductory remarks. And we'll dive into a little bit of Q&A, if that's okay.

James R. Hollingshead
Insulet Corporation - President, CEO & Director

Great. That's perfect. Thanks, Josh. Thanks for having us. Good morning, everybody. Great to see you all. Just a couple of quick comments. I'm guessing most of you in the room know us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot